- Home
- ANIX vs MASS Comparison
ANIX vs MASS Comparison
Compare ANIX & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- MASS
- Stock Information
- Founded
- ANIX 1982
- MASS 2012
- Country
- ANIX United States
- MASS United States
- Employees
- ANIX N/A
- MASS N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- ANIX Health Care
- MASS Health Care
- Exchange
- ANIX Nasdaq
- MASS Nasdaq
- Market Cap
- ANIX 84.7M
- MASS 84.3M
- IPO Year
- ANIX 1987
- MASS 2020
- Fundamental
- Price
- ANIX $2.63
- MASS $5.79
- Analyst Decision
- ANIX Strong Buy
- MASS Buy
- Analyst Count
- ANIX 3
- MASS 3
- Target Price
- ANIX $9.00
- MASS $5.33
- AVG Volume (30 Days)
- ANIX 36.2K
- MASS 456.1K
- Earning Date
- ANIX 06-03-2025
- MASS 05-13-2025
- Dividend Yield
- ANIX N/A
- MASS N/A
- EPS Growth
- ANIX N/A
- MASS N/A
- EPS
- ANIX N/A
- MASS N/A
- Revenue
- ANIX N/A
- MASS $59,631,000.00
- Revenue This Year
- ANIX N/A
- MASS N/A
- Revenue Next Year
- ANIX N/A
- MASS $18.84
- P/E Ratio
- ANIX N/A
- MASS N/A
- Revenue Growth
- ANIX N/A
- MASS 18.72
- 52 Week Low
- ANIX $2.07
- MASS $1.81
- 52 Week High
- ANIX $4.20
- MASS $7.48
- Technical
- Relative Strength Index (RSI)
- ANIX 42.93
- MASS 66.62
- Support Level
- ANIX $2.70
- MASS $5.01
- Resistance Level
- ANIX $2.84
- MASS $5.73
- Average True Range (ATR)
- ANIX 0.16
- MASS 0.41
- MACD
- ANIX -0.01
- MASS -0.00
- Stochastic Oscillator
- ANIX 25.62
- MASS 89.58
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.